Sudair Pharmaceutical Company
Ehtesham Chatriwala has extensive work experience in finance and accounting roles. ehtesham began their career as an Audit Senior at Big 4 Audit firms, where they gained exposure to various industries and developed strong auditing and reporting skills. ehtesham then worked as Vice President at Apple Finance Limited, where they were responsible for budgets, MIS, and establishing a comprehensive management information system. ehtesham later joined S.B.I Mutual Fund as Vice President - Operations, overseeing functions such as preparation of fund accounts and monitoring service providers. ehtesham also had their own professional practice, E.A. Chatriwala & Co., before joining Jeddah BioCity Company as the Group Financial Controller. In this role, they prepared and consolidated group financial statements and implemented an effective financial reporting system. ehtesham then served as Finance Director at Arab Company for Pharmaceutical Products, where they managed financial reporting, borrowing from banks, treasury management, and budget preparation. Most recently, they held the position of Finance Director at CAD Middle East Pharmaceutical Industries LLC and Sudair Pharmaceutical Company, where they likely continued to utilize their skills and experience in finance and accounting.
Ehtesham Chatriwala holds a B.Com. degree and is an ACA from The Institute of Chartered Accountants of India. The details of their education history, such as the start and end years of their studies or any field of study, are not provided.
This person is not in any teams
This person is not in any offices
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.